These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5264689)

  • 21. Effects of phenobarbital and diphenylhydantoin on acute vitamin D3 toxicity in the rat.
    Gascon-Barré M; Côté MG
    Toxicol Appl Pharmacol; 1978 Jan; 43(1):125-35. PubMed ID: 204079
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of several drugs on the in vivo and in vitro activity of mammalian hepatic azo-reductase.
    Burba JV
    Can J Biochem; 1968 Apr; 46(4):367-71. PubMed ID: 5661678
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug interactions. 3. Therapeutic implications of enzyme induction.
    Soyka LF
    Pediatrics; 1972 Sep; 50(3):489-90. PubMed ID: 5056430
    [No Abstract]   [Full Text] [Related]  

  • 24. Further observations on the interactions between phenobarbital and diphenylhydantoin during chronic treatment in the rat.
    Rizzo M; Morselli PL; Garattini S
    Biochem Pharmacol; 1972 Feb; 21(4):449-54. PubMed ID: 5014504
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of the effects of propylthiouracil, amiodarone, diphenylhydantoin, phenobarbital, and 3-methylcholanthrene on hepatic and renal T4 metabolism and thyroid gland function in rats.
    De Sandro V; Chevrier M; Boddaert A; Melcion C; Cordier A; Richert L
    Toxicol Appl Pharmacol; 1991 Nov; 111(2):263-78. PubMed ID: 1957312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of liver microsomal cortisol 6beta-hydroxylase by diphenylhydantoin or phenobarbital: an explanation for the increased excretion of 6-hydroxycortisol in humans treated with these drugs.
    Conney AH; Jacobson M; Schneidman K; Kuntzman R
    Life Sci; 1965 May; 4(10):1091-8. PubMed ID: 5838511
    [No Abstract]   [Full Text] [Related]  

  • 27. Difference in the central actions of phenytoin and phenobarbitone in man, measured by critical flicker fusion threshold.
    Houghton GW; Latham AN; Richens A
    Eur J Clin Pharmacol; 1973 Jun; 6(1):57-60. PubMed ID: 4587516
    [No Abstract]   [Full Text] [Related]  

  • 28. The effects of phenytoin on phenobarbitone and primidone metabolism.
    Lambie DG; Johnson RH
    J Neurol Neurosurg Psychiatry; 1981 Feb; 44(2):148-51. PubMed ID: 7217971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folate deficiency and anticonvulsant drugs.
    Spray GH; Burns DG
    Br Med J; 1972 Apr; 2(5806):167-8. PubMed ID: 5017316
    [No Abstract]   [Full Text] [Related]  

  • 30. [Calcium metabolism disorders in antiepileptic therapy].
    Schaefer K; von Herrath D; Kraft D
    Dtsch Med Wochenschr; 1973 May; 98(20):1043-6. PubMed ID: 4350570
    [No Abstract]   [Full Text] [Related]  

  • 31. Phenobarbital and phenytoin effects on somatosensory evoked potentials and spontaneous EEG in normal cat brain.
    Kaplan BJ
    Epilepsia; 1977 Sep; 18(3):397-403. PubMed ID: 891493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of rat liver calciferol 25-hydroxylase activity with anticonvulsant drugs.
    Sulimovici S; Roginsky MS
    Life Sci; 1977 Nov; 21(9):1317-22. PubMed ID: 200813
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum concentrations of diphenylhydantoin (phenytoin) and phenobarbital and their relation to therapeutic and toxic effects.
    Buchthal F; Svensmark O
    Psychiatr Neurol Neurochir; 1971; 74(2):117-36. PubMed ID: 5004709
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of inositol, diphenylhydantoin and phenobarbital on HEOD storage in rat adipose tissue.
    Cook RM
    Bull Environ Contam Toxicol; 1973 Jun; 9(6):370-5. PubMed ID: 4780440
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of the anticonvulsants phenobarbital and diphenylhydantoin on intestinal absorption of calcium.
    Foss MC; Meneghelli UG; Tabosa Veríssimo JM
    Acta Physiol Lat Am; 1979; 29(4-5):223-8. PubMed ID: 263172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stabilization of excitable membrane by chronic administration of diphenylhydantoin.
    Julien RM; Halpern LM
    J Pharmacol Exp Ther; 1970 Oct; 175(1):206-12. PubMed ID: 5471447
    [No Abstract]   [Full Text] [Related]  

  • 37. Differential effects of baclofen, gamma-hydroxybutyric acid and muscimol on the protective action of phenobarbital and diphenylhydantoin against maximal electroshock-induced seizures in mice.
    Czuczwar SJ; Chmielewska B; Turski WA; Kleinrok Z
    Neuropharmacology; 1984 Feb; 23(2A):159-63. PubMed ID: 6717755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the glucaric acid pathway in the metabolism of D-glucuronic acid in mammals. V. Stimulatory effect of diphenylhydantoin and phenobarbital on the D-glucaric acid synthesis in man.
    Okada M; Matsui M; Kaizu T; Abe F
    Chem Pharm Bull (Tokyo); 1969 Dec; 17(12):2625-8. PubMed ID: 5373168
    [No Abstract]   [Full Text] [Related]  

  • 39. Increase of the teratogenic power of diphenylhydantoin by phenobarbital in mice.
    Mercier-Parot L; Tuchmann-Duplessis H
    C R Acad Hebd Seances Acad Sci D; 1977 Jul; 285(3):245-7. PubMed ID: 409561
    [No Abstract]   [Full Text] [Related]  

  • 40. Diphenylhydantoin and phenobarbital suppress the dopaminergic neurotoxicity of MPTP in mice.
    Melamed E; Martinovits G; Pikarsky E; Rosenthal J; Uzzan A
    Eur J Pharmacol; 1986 Sep; 128(3):255-7. PubMed ID: 3491762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.